{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-074369","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2023-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.834881+00:00","generated_at":"2026-06-13T17:13:11.267572+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Gain Therapeutics stockholders elect all 8 director nominees, ratify EY as auditor","bullets":["All 8 director nominees elected; highest votes for Gwen Melincoff (3,719,922 for), lowest for Hans Peter Hasler (3,491,745 for).","Ernst & Young AG ratified as independent auditor for FY2023 with 7,927,104 votes for, 4,642 against, 11,513 abstentions.","Annual meeting held June 23, 2023; quorum present and all proposals passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-074369","json":"https://secwatch.observer/filing/0001104659-23-074369.json","markdown":"https://secwatch.observer/filing/0001104659-23-074369.md","text":"https://secwatch.observer/filing/0001104659-23-074369.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923074369/0001104659-23-074369-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923074369/tm2319589d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:13:11.267572+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5733298a7320c21b21bca1e742bfb8ee0b5be6c0","claim":"Gain Therapeutics, Inc. shareholders approved Ratification of selection of Ernst & Young AG as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-23 meeting.","evidence_excerpt":"Proposal 2 – Ratification of the Selection by the Audit Committee of the Board of Directors of Ernst & Young AG as the Independent Registered Public Accounting Firm of the Company for its Fiscal Year Ending December 31, 2023 The Company’s stockholders approved Proposal 2. The votes cast were as follows: For Against Abstain 7,927,104 4,642 11,513","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923074369/0001104659-23-074369-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-23"}],"fact_type":"shareholder_vote"},{"claim_id":"b05ef3d2088dcef32ab176cc2c553baca0761c10","claim":"Gain Therapeutics, Inc. shareholders approved Election of eight nominees for director to serve until 2024 Annual Meeting at the 2023-06-23 meeting.","evidence_excerpt":"Proposal 1 - Election of Directors The Company’s stockholders elected the eight persons listed below as directors, each to serve until the Company’s 2024 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The votes cast were as follows: Nominees For Withheld Broker Non-Votes Matthias Alder 3,718,412 19,996 4,204,851 Dov Goldstein, M.D. 3,659,322 79,086 4,204,851 Hans Peter Hasler 3,491,745 246,663 4,204,851 Khalid Islam, Ph.D. 3,684,791 53,617 4,204,851 Gwen Melincoff 3,719,922 18,486 4,204,851 Claude Nicaise, M.D. 3,648,185 90,223 4,204,851 Eric I. Richman 3,711,215 27,193 4,204,851 Jeffrey Riley 3,716,202 22,206 4,204,851","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923074369/0001104659-23-074369-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-23"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}